Cleared Traditional

K832980 - VXTRA OCUTOME KIT

K832980 is an FDA 510(k) clearance for VXTRA OCUTOME KIT, manufactured by Vxtra Corp.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 47-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1983
Decision
47d
Days
Class 2
Risk

K832980 is an FDA 510(k) clearance for the VXTRA OCUTOME KIT. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Vxtra Corp. (Mchenry, US). The FDA issued a Cleared decision on October 19, 1983 after a review of 47 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K832980

510(k) Number K832980 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 02, 1983
Decision Date October 19, 1983
Days to Decision 47 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 110d · This submission: 47d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 316
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K832980.
EXTRA SENSORY PLUS
K834158 · American Surgical Co., Inc. · Dec 1983
PHACOTRON PLUS
K834159 · American Surgical Co., Inc. · Dec 1983
UNIVERSAL PAC
K834161 · American Surgical Co., Inc. · Dec 1983
SIAS IRRIGATION/ASPIRATION SYSTEM
K832413 · Clark Pool & Assoc. · Oct 1983
EPA AUTOMATED INFUSION POLE
K832997 · Miami Eye Technology, Inc. · Oct 1983
OCUCARE FREEDOM PACK
K832559 · Ocular Innovations, Inc. · Sep 1983